RecruitingNot ApplicableNCT06927076

Antidepressant Response of DMT Masked With Propofol

Investigating the Role of the Psychedelic Experience in the Antidepressant Response in Patients With Major Depression: a Placebo-controlled Factorial Trial With DMT Masked With Propofol (DMT4D-Study)


Sponsor

University Hospital, Basel, Switzerland

Enrollment

112 participants

Start Date

Aug 5, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to elucidate if the anti-depressive effect of N,N-dimethyltryptamine (DMT) is based on a biological mechanisms including neuroplasticity and anti-inflammatory effect or due to the subjective psychedelic experience.


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether DMT (dimethyltryptamine — a naturally occurring psychedelic compound) given alongside propofol (a sedative used to mask the psychedelic experience) can reduce symptoms of moderate to severe depression. The goal is to explore DMT's antidepressant effects while removing the psychedelic experience. **You may be eligible if...** - You are 21 or older - You have moderate to severe depression (MADRS score above 20) - You are either not on antidepressants, or have been on a stable dose for at least 4 weeks - You are fluent in German - You are willing to avoid alcohol, heavy smoking, and illicit substances during the study **You may NOT be eligible if...** - You have a personal or family history of psychosis, schizophrenia, or bipolar disorder - You have a serious heart, liver, or kidney condition - You are currently pregnant or breastfeeding - You have active suicidal thoughts with a plan - You have a substance use disorder Talk to your doctor to see if this trial is right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGN,N-Dimethyltryptamine

administration of a 2mg/min DMT perfusion over 20 min

DRUGPlacebo

administration of a placebo perfusion over 20 min

PROCEDUREPropofol

30 min propofol sedation

PROCEDUREno sedation

no sedation


Locations(1)

University Hospital Basel

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06927076


Related Trials